Get started
Author

Raquel Caballero

Observed name: R. Caballero
Institution: Inmunotek (Spain)
ORCID: 0000-0001-5012-0340
Observed ORCID: 0000-0001-5012-0340
OpenAlex ID: A5021851311
Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections
2022 · María-Fernanda Lorenzo-Gómez, Stephen Foley, et al. · NEJM Evidence · 85
Safety of an Ultra-Rush Immunotherapy Build-Up Schedule with Therapeutic Vaccines Containing Depigmented and Polymerized Allergen Extracts
2005 · M. Casanovas, R. Martín, et al. · International Archives of Allergy and Immunology · 43
Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts
2007 · M. Casanovas, R. Martín, et al. · Clinical & Experimental Allergy · 36
First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
2022 · Antonio Nieto, Ángel Mazón, et al. · Allergy · 30
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults
2024 · Karla Montalbán-Hernández, Ana Cogollo-García, et al. · Vaccines · 23
PDF
Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study
2024 · Miguel Casanovas, Pedro Ojeda, et al. · Frontiers in Immunology · 21
Safety of immunotherapy with glutaraldehyde modified allergen extracts in children and adults
2016 · M. Guzmán-Fulgencio, R. Caballero, et al. · Allergologia et Immunopathologia · 19
Reducing Recurrent Urinary Tract Infections in Women with MV140 Impacts Personal Burden of Disease: Secondary Analyses of a Randomized Placebo-controlled Efficacy Study
2024 · J. Curtis Nickel, Stephen Foley, et al. · European Urology Open Science · 14
Combination of Allergic Asthma Symptom and Medication Scores in Allergen Immunotherapy Trials: A Proposal
2021 · Raquel Caballero, Alicia Grau, et al. · International Archives of Allergy and Immunology · 8
PDF
Safety of immunotherapy with Alternaria alternata glutaraldehyde–polymerized allergen extract in adults and children
2024 · Raquel Caballero, Gracia Javaloyes, et al. · Allergologia et Immunopathologia · 4
PDF
Mp02-15 Impact of Mv140 on Patient Related Burden of Disease Associated With the Management of Recurrent Urinary Tract Infections (ruti)
2022 · J. Curtis Nickel, Stephen Foley, et al. · The Journal of Urology · 3
Prevention of COPD exacerbations with a mucosal trained immunity–based vaccine (MV130): a randomised phase 3 trial
2026 · Luis Puente Maestu, Myriam Calle Rubio, et al. · European Respiratory Journal · 1
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
2021 · Laura Conejero Hall, Luis Puente Maestu, et al. · European Respiratory Journal · 1
Late Breaking Abstract - MV130, a Trained Immunity-based Vaccine, in the prevention of RRTIs in adults: A retrospective study
2023 · Laura Conejero Hall, Karla Montalbán, et al. · European Respiratory Journal
Late Breaking Abstract - Management of RRTIs in children with the Trained Immunity-based Vaccine MV130: A retrospective study
2023 · Laura Conejero Hall, Karla Montalbán, et al. · European Respiratory Journal
Allergen-induced Expression Of Il-25 And Il-25 Receptor In Asthmatic Airways And In Allergen-induced Late Phase Cutaneous Responses In Atopic Subjects
2011 · S. Ying, W. Wang, et al. · Journal of Allergy and Clinical Immunology
PDF
Works count: 16
Citation count: 288
H-index: 8
I10-index: 8
Year
Topic
Type